In this video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, discusses how regulatory ...

In today's ACT Brief, we explore the data overload and alert fatigue challenges in integrating wearable data into clinical ...

In this video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, examines the operational challenges ...

In this video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, explains how continuous remote ...

Ultimately, the data and technology systems validation capability can become a strategic differentiator that enables faster trials, higher data quality, and superior regulatory readiness as study ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, reflects on the growing role of Bayesian ...

In today's ACT Brief, we examine the technology infrastructure gap facing investigator-initiated trials, how transparency and community engagement drive vaccine adoption, and why workflow ...

In today's ACT Brief, we explore how wearable data is informing real-world clinical decision-making, a statistical method that analyzes multiple patient outcomes simultaneously to improve trial design ...

The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug development. The guidance, ...

In today's ACT Brief, we explore how continuous remote monitoring enables early clinical interventions, FDA guidance on validating new approach methodologies as alternatives to animal testing, and the ...

Finally, we turn to how we do. Behavioral science provides powerful models for performance: motivation, ability, and environmental nudges determine whether new knowledge translates into consistent ...

Vaccine hesitancy is widely recognized as one of the most significant public health problems of the 21 st Century. The World Health Organization (WHO) identifies vaccine hesitancy ...